RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/7EAD391B8B6A737B216925AAFC0F1A407EF7EE38BC6B39BD837F935B47359C95F0F7E688DE64BD78EB0FE17AAAD22572http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/7EAD391B8B6A737B216925AAFC0F1A407EF7EE38BC6B39BD837F935B47359C95F0F7E688DE64BD78EB0FE17AAAD22572http://www.w3.org/2000/01/rdf-schema#comment"Knockdown of TKTL1 additively complements cisplatin-induced cytotoxicity in the nasopharyngeal carcinoma cells by inhibiting the levels of NADPH and ribose-5-phosphate indicating that TKTL1 may be a promising target to improve the therapeutic effect combining with cisplatin for the patients with nasopharyngeal carcinoma."xsd:string
http://purl.uniprot.org/uniprot/#_7585EA4A53346EB5F4741F58E7952F48421BDF588FAFA4F09063CAC4CA4A9CE17D3F5073DF9C737EC373679AA1FE9063http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/7EAD391B8B6A737B216925AAFC0F1A407EF7EE38BC6B39BD837F935B47359C95F0F7E688DE64BD78EB0FE17AAAD22572
http://purl.uniprot.org/uniprot/B7Z7M4http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/7EAD391B8B6A737B216925AAFC0F1A407EF7EE38BC6B39BD837F935B47359C95F0F7E688DE64BD78EB0FE17AAAD22572
http://purl.uniprot.org/uniprot/#_B7Z7M4-mappedCitation-27916418http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/7EAD391B8B6A737B216925AAFC0F1A407EF7EE38BC6B39BD837F935B47359C95F0F7E688DE64BD78EB0FE17AAAD22572